Rexam PLC confirms that it has completed the sale of the Pharmaceutical Devices and Prescription Retail Packaging divisions of its Healthcare business to Montagu Private Equity for a total cash consideration of US$805 million, subject to customary closing adjustments.
As previously announced, following completion Rexam proposes to return £450m of the proceeds to shareholders by way of a B and C share scheme together with a share capital consolidation.
Rexam Completes Sale of Pharmaceutical Devices and Prescription Retail Packaging Divisions
Published May 9, 2014
blog comments powered by Disqus